Syndax Pharmaceuticals (NASDAQ:SNDX) is scheduled to announce Q2 earnings results on Monday, August 4th, after market close.

Exxon Mobil’s profit dropped in the second quarter to the lowest level in four years as oil prices declined amid an increase ...

Data from Square shows that the average tip on food and beverage transactions has dipped, though drink purchases at bars ...

Installations expected to reach 40,000 homes across North America; company advances toward cash flow positivity in 2025 ...

Regeneron topped Wall Street estimates for second-quarter results on Friday, on robust demand for its blockbuster eczema drug ...

PROS Holdings grew subscription revenue 12% in Q2, well ahead of management’s guidance range. Click here to find out why PRO ...

Capstone Copper Corp.'s strong execution at Mantoverde and growth projects like Santo Domingo signal long-term value. Click ...

Q2 2025 Management View CEO Jude I. Bricker emphasized the company's unique, diversified business model, noting "our diverse ...

Key Points Adjusted diluted EPS (non-GAAP) exceeded estimates by $0.06 in Q2 2025 and GAAP revenue surpassed forecasts by $31 million in Q2 2025. North American LTL adjusted operating ratio improved ...

Trump Media & Technology Group, the parent company of Truth Social that is majority-owned by President Donald Trump, posted ...

Much like the last day of July, the first day of August brought a quiet morning and an active afternoon and evening to ...

Key Points GAAP revenue for Q2 2025 was $88.6 million, coming in about $1.3 million below analyst consensus. Adjusted EBITDA margin improved to 32%, up from 27% in Q2 2024. Glo Fiber Expansion Markets ...